There was an error in the original article [1]. The authors wish to remove words “of this prospective trial” from the last paragraph of Section 1 (on Page 4, row 8) and delete “prospective clinical” from Section 4.1 (first sentence of this Section on Page 8). The corrected sentences are as follows:
In last paragraph of Section 1 (on Page 4, row 8): “The aim was to critically assess the possible benefits of IP in the prevention and treatment of COVID-19 in nursing home settings.” and in Section 4.1 (first sentence of this Section on Page 8), “This study was performed in three nursing homes in three towns (Litovel, Sanatorium Topas Holice, and Beránek Úpice) in the Czech Republic”.
The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Reference
- 1.Beran J., Špajdel M., Katzerová V., Holoušová A., Malyš J., Rousková J.F., Slíva J. Inosine Pranobex Significantly Decreased the Case-Fatality Rate among PCR Positive Elderly with SARS-CoV-2 at Three Nursing Homes in the Czech Republic. Pathogens. 2020;9:1055. doi: 10.3390/pathogens9121055. [DOI] [PMC free article] [PubMed] [Google Scholar]